{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:34:00Z","timestamp":1789781640359,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73798-3","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:08:17Z","timestamp":1779926897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["BNT162b2 LP.8.1 early vaccine effectiveness against COVID-19 emergency department, urgent care, and outpatient visits"],"prefix":"10.1038","volume":"17","author":[{"given":"Haley J.","family":"Appaneal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrishali V.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-9641","authenticated-orcid":false,"given":"Hannah R.","family":"Volkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan J.","family":"Zasowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-027X","authenticated-orcid":false,"given":"Aisling R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"73798_CR1","unstructured":"FDA. COVID-19 Vaccines (2025-2026 Formula) for Use in the United States Beginning in Fall 2025. Accessed December 9, 2025. https:\/\/www.fda.gov\/vaccines-blood-biologics\/industry-biologics\/covid-19-vaccines-2025-2026-formula-use-united-states-beginning-fall-2025."},{"key":"73798_CR2","unstructured":"CDC. Staying Up to Date with COVID-19 Vaccines. Accessed December 8, 2025. https:\/\/www.cdc.gov\/covid\/vaccines\/stay-up-to-date.html."},{"key":"73798_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.14740\/jocmr5145","volume":"16","author":"N Mielke","year":"2024","unstructured":"Mielke, N., Johnson, S., O\u2019Sullivan, C., Toseef, M. U. & Bahl, A. Updated Bivalent COVID-19 Vaccines Reduce Risk of Hospitalization and Severe Outcomes in Adults: An Observational Cohort Study. J. Clin. Med. Res. 16, 208\u2013219 (2024).","journal-title":"J. Clin. Med. Res."},{"key":"73798_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59344-7","volume":"16","author":"HJ Appaneal","year":"2025","unstructured":"Appaneal, H. J. et al. Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System. Nat. Commun. 16, 4033 (2025).","journal-title":"Nat. Commun."},{"key":"73798_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53842-w","volume":"15","author":"AR Caffrey","year":"2024","unstructured":"Caffrey, A. R. et al. Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System. Nat. Commun. 15, 9490 (2024).","journal-title":"Nat. Commun."},{"key":"73798_CR6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","volume":"393","author":"J Scott","year":"2025","unstructured":"Scott, J. et al. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N. Engl. J. Med. 393, 2221\u20132242 (2025).","journal-title":"N. Engl. J. Med."},{"key":"73798_CR7","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jamainternmed.2025.5465","volume":"185","author":"Y Du","year":"2025","unstructured":"Du, Y., Paritala, S., Xu, Y., Maloney, P. & Lin, D. Y. Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants. JAMA Intern. Med. 185, 1501\u20131504 (2025).","journal-title":"JAMA Intern. Med."},{"key":"73798_CR8","doi-asserted-by":"crossref","unstructured":"Ma, H. et al. Effectiveness of the monovalent XBB.1.5 COVID-19 vaccines: A systematic review and meta-analysis. J. Microbiol. Immunol. Infect. (2025).","DOI":"10.1016\/j.jmii.2025.07.002"},{"key":"73798_CR9","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","volume":"42","author":"S Song","year":"2024","unstructured":"Song, S. et al. A systematic review and. meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants. Vaccine 42, 3389\u20133396 (2024).","journal-title":"Vaccine"},{"key":"73798_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1322396","volume":"10","author":"MQ Cheng","year":"2023","unstructured":"Cheng, M. Q., Li, R., Weng, Z. Y. & Song, G. Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis. Front Med. 10, 1322396 (2023).","journal-title":"Front Med."},{"key":"73798_CR11","unstructured":"National Foundation for Infectious Diseases. NFID Calls for Evidence-Based Guidance as Many People Skip Life-Saving Respiratory Vaccines. Accessed 2025. https:\/\/www.nfid.org\/nfid-calls-for-evidence-based-guidance-as-many-people-skip-life-saving-respiratory-vaccines\/."},{"key":"73798_CR12","unstructured":"CDC. Vaccination Trends. Accessed 2025. https:\/\/www.cdc.gov\/respiratory-viruses\/data\/vaccination-trends.html."},{"key":"73798_CR13","doi-asserted-by":"crossref","unstructured":"Barello S, et al. Exploring the Motivational Roots of Getting Vaccinated against COVID-19 in a Population of Vaccinated Pediatric Healthcare Professionals: Evidence from an Italian Cross-Sectional Study. Vaccines. 2022;10.","DOI":"10.3390\/vaccines10030467"},{"key":"73798_CR14","unstructured":"CDC. Advisory Committee on Immunization Practices. Updates to COVID-19 Vaccine Effectiveness. Accessed 2025."},{"key":"73798_CR15","unstructured":"CDC. Vaccination Trends. Accessed 2024. https:\/\/www.cdc.gov\/respiratory-viruses\/data\/vaccination-trends.html#cdc_data_surveillance_section_3-covid-19-vaccine."},{"key":"73798_CR16","unstructured":"HHS. CDC Immunization Schedule Adopts Individual-Based Decision-Making for COVID-19 and Standalone Vaccination for Chickenpox in Toddlers. Accessed 2025. https:\/\/www.hhs.gov\/press-room\/cdc-immunization-schedule-individual-decision-covid19-standalone-chickenpox-toddlers.html."},{"key":"73798_CR17","unstructured":"Veterans Health Administration. About VHA. Accessed 2026. https:\/\/www.va.gov\/health\/aboutvha.asp."},{"key":"73798_CR18","unstructured":"National Center for Veterans Analysis and Statistics. VA Statistics at a Glance Pocket Card. Accessed 2026. https:\/\/www.va.gov\/VETDATA\/docs\/pocketcards\/pocketcard.pdf."},{"key":"73798_CR19","unstructured":"U.S. Department of Veterans Affairs. Department of Veterans Affairs COVID-19 National Summary. Accessed 2024. https:\/\/www.accesstocare.va.gov\/Healthcare\/COVID19NationalSummary."},{"key":"73798_CR20","unstructured":"Pfizer Inc. Pfizer and BioNTech\u2019s COMIRNATY\u00ae Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19. Accessed 2026. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontechs-comirnatyr-receives-us-fda-approval."},{"key":"73798_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3934\/publichealth.2021042","volume":"8","author":"C Kitchen","year":"2021","unstructured":"Kitchen, C., Hatef, E., Chang, H. Y., Weiner, J. P. & Kharrazi, H. Assessing the association between area deprivation index on COVID-19 prevalence: a contrast between rural and urban U.S. jurisdictions. AIMS Public Health 8, 519\u2013530 (2021).","journal-title":"AIMS Public Health"},{"key":"73798_CR22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/gerona\/glab071","volume":"76","author":"D Cheng","year":"2021","unstructured":"Cheng, D. et al. Updating and validating the U.S. Veterans Affairs Frailty Index: Transitioning from ICD-9 to ICD-10. J. Gerontol. A Biol. Sci. Med Sci. 76, 1318\u20131325 (2021).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"73798_CR23","volume":"9","author":"SY Tartof","year":"2022","unstructured":"Tartof, S. Y. et al. Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study. Lancet Reg. Health Am. 9, 100198 (2022).","journal-title":"Lancet Reg. Health Am."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73798-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73798-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73798-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:02:01Z","timestamp":1784952121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73798-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73798"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73798-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Haley J. Appaneal has received research funding from Pfizer and Merck. Vrishali V. Lopes has no competing interests to declare. Jennifer L. Nguyen, Hannah R. Volkman, and Evan J. Zasowski are employees and shareholders of Pfizer Inc. Aisling R. Caffrey has received research funding from Pfizer.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6912"}}